Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Jennifer C. Y. Sung, PharmD, MS;Michael B. Nichol, PhD;Francesca Venturini, PharmD, MS;Karen L. Bailey, PharmD, MS;Jeffrey S. McCombs, PhD;Marisu;

Publication

Article

October 1, 1998

The American Journal of Managed Care

October 1998

Volume4

Issue 10

Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Author(s):

Jennifer C. Y. Sung, PharmD, MS,Michael B. Nichol, PhD

Download PDF: Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Articles in this issue

Clinic Visits and Hospital Admissions for Care of Acid-Related Upper Gastrointestinal Disorders in Women Using Alendronate for Osteoporosis

Attitudes Toward Cost-Containment Features of Managed Care: Differences Among Patient Subgroups

An Investigation of Primary Care Patients Receiving Extended Treatment With Selective Serotonin Reuptake Inhibitors

Where Is the Financial Safety Net for Managed Care Physicians

Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Empiric Investigation on Direct Costs-of-Illness and Healthcare Utilization of Medicaid Patients With Diabetes Mellitus

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Newsletter